Dual-component organic nanoparticles are prepared by a modified emulsion-templated freeze-drying approach to give an aqueous nanosuspensions showing Fluorescence (Förster) Resonance Energy Transfer (FRET) from within a distribution of single nanoparticles, dissolution of these particles results in loss of this FRET signal. Incubation of the particles with cells and analysis by confocal microscopy allows spatial and physical monitoring of the particles after internalization. The formation of dual-component organic nanoparticles by a modified emulsion-templated freeze-drying approach has led to aqueous nanosuspensions showing Fluorescence (Förster) Resonance Energy Transfer (FRET) from within a distribution of single nanoparticles. The combination of both FRET dyes within dual-component nanoparticles (<200 nm) allows the spatial and physical monitoring of the particles as the FRET signal is lost on dissolution and
breakdown of the nanoparticles. The monitoring of accumulation by Caco-2 cells and macrophages shows very limited internalization within the non-phagocytic cells.
Conservation of FRET within the macrophages confirms extensive whole-particle internalization. The cellular permeability through Caco-2 monolayers was also assessed and movement of intact dual-component particles was observed, suggesting a mechanism for enhanced pharmacokinetics in vivo.
Introduction
The use of nanosuspensions, particles of pure drug in the sub-micron size range, [1] has been heralded as an approach to address the issue of formulating poorly soluble active pharmaceutical ingredients (API) [2] [3] [4] [5] [6] [7] [8] [9] and has been successful in producing a range of new medicines, dosed daily in clinics globally.
These include the immunosuppressant Rapamune® (rapamycin), the chemotherapy-induced nausea prevention medicine Emend® (aprepitant) and the hypercholesterolemia treatment TriCor® (fenofibrate). The solid drug particles do not utilize a drug carrier or a drug vehicle, such as vesicles, micelles or pegylation, [10] to overcome poor solubility, therefore each particle conveys high drug content, offering an efficient way to deliver drugs to, and/or into, cells. Additionally, formulating a poorly-soluble drug as a nanosuspension has been shown to enhance dissolution rate and improve bioavailability [7, 11, 12] over conventional drug formulation approaches.
The in vivo behavior of drugs in various nanoparticle forms has been subject to a considerable amount of research. [13] [14] [15] Ongoing study continues to investigate the cellular uptake and accumulation of a wide range of nanoparticles, nanoparticulate drug delivery systems and colloidal particles with a specific emphasis on toxicity. [14, 16] Nanosuspensions, typically composed of aggregates or crystals of poorly-soluble organic molecules, have a finite solubility and do not utilize a nanoscopic vehicle for delivery, therefore the nanoparticles will undergo continuous dissolution within the body.
The Caco-2 cell line, originating from human colorectal carcinoma, has been shown to spontaneously differentiate in culture to form a confluent monolayer with morphological and functional similarities to the small intestinal epithelium. [17] As a result of these characteristics the Caco-2 monolayer has been developed as a model to study a range of therapeutic agents and delivery vehicles (microparticles, [18] nanoparticles [19] and nanocomplexes [20] ). Hu and coworkers compared the uptake into Caco-2 cells (human intestinal, non-phagocytic) and phagocytic cells (mouse macrophage RAW cells) of charcoal nanoparticles and a pyrene nanosuspension, using optical microscopy. [21] Both types of particle displayed similar uptake behavior; limited in the Caco-2 cells but extensive in the RAW cells. The limitations of optical microscopy led to a lack of clarity regarding whether the pyrene particles were indeed internalized intact or transported as dissolved molecules with subsequent accumulation within the cell. Other studies have shown that nanosuspensions of hydrophobic drugs, produced by milling, gave an increase in the apparent permeability through a Caco-2 monolayer compared to un-milled drug. The authors suggested that improvement of oral bioavailability was due to increased dissolution rather than movement of particles through the cells of the gastrointestinal (GI) tract. [2] The transport and fate of nanosuspensions within the body is therefore relatively poorly understood with respect to; a) whether particles, when orally dosed, cross the GI tract and enter the circulation intact, b) whether dissolution occurs before cellular uptake and c) whether particles remain intact over considerable timescales after uptake into phagocytic cells. Accurate monitoring of the physical state of nanosuspensions, and their dissolution, is therefore key to the study of cellular uptake.
Cellular uptake of block copolymer micelle drug delivery vehicles was investigated by
Cheng and co-workers [22] using Fluorescence (Förster) Resonance Energy Transfer (FRET). [23] FRET relies upon non-radiative energy transfer (long-range, <10 nm, dipoledipole coupling) from a donor fluorophore in an electronic excited state, to a second fluorophore, the acceptor. A FRET signal is observed when the donor molecule is excited and transfers its energy to the acceptor, resulting in acceptor emission.
The micelles were loaded with a pair of FRET dyes (donor and acceptor) and were considered intact if a FRET signal was observed, indicating close proximity of the donor and acceptor fluorophores within the hydrophobic interior of the micelle. Decomposition of the micelles, or release of dye from the micelle, caused a loss in the FRET signal as the two fluorophore molecules became dissociated resulting in loss of energy transfer. We were interested in using the same concept to monitor the physical state of the particles during cellular uptake however, traditional top-down approaches used to produce nanosuspensions (such as milling or high-pressure homogenization) are not suitable for producing nanoparticles that contain two different organic molecules.
In this paper we use a simple modified emulsion-templated freeze-drying method [24] to produce a dual-component hydrophobic nanosuspension where particles contain a FRET fluorophore pair. We demonstrate that these particles indeed contain both fluorophores and that dissolution of the particles was accompanied by dramatic reduction in the FRET signal.
These particles were used to investigate cellular uptake into human monocyte derived macrophages (activated THP-1 cells -A-THP-1) and Caco-2 cells before assessing the permeability of these particles through a Caco-2 cell monolayer.
Results and Discussion

Nanosuspension synthesis and characterization.
Single component, containing one fluorophore, and dual-component, containing both acceptor and donor fluorophores, nanosuspensions were prepared by a modified emulsiontemplated freeze-drying method ( Fig. 1) Figure 1S ). Zeta potential measurements of the nanosuspensions also indicated similar values which appeared to be largely independent of composition (10-12 mV (+/-4 mV)), the minor cationic charge of the nanosuspensions arising from DiO and DiI. The low zeta potentials suggest that colloidal stability was given by the steric stabilization from adsorbed PVA and the overall similarity of the particles was considered appropriate for direct comparative studies. The nanoparticles were imaged using a graphene oxide (GO) support. Previous reports have demonstrated the advantages of using GO as a low contrast support for transmission electron microscopy (TEM) [25] [26] [27] [28] and recently as a support for multi-technique imaging by TEM, scanning electron microscopy (SEM) and atomic force microscopy (AFM). [29] The three techniques can be performed concurrently on the same GO-grid, simplifying the collection of complementary images. Furthermore the nature of the GO grid allows for images to be collected unstained and uncoated, minimizing misinterpretation of data and allowing for more accurate correlation of results. The morphology of the particles was first examined by TEM and SEM ( Fig. 2B&C) and irregular, asymmetric shapes with a high aspect ratio were observed using both techniques. Characterization of the particles by AFM ( Fig. 2D&E ) yielded a similar morphology; flattened asymmetric particles in the same size range as determined by SEM and TEM. Although the sizes determined by TEM, SEM and AFM appear to be smaller than the DLS measurements, all values are consistent in showing the formation of <200 nm particles, especially when considering the approximation to spheres that is inherent in DLS measurement. Analysis of the materials by x-ray powder diffraction (XRPD) revealed that the particles were composed of the fluorophores in an amorphous state (SI Figure 2S ).
Characterizing nanosuspension fluorescence and FRET emission. FRET is a well
established method used primarily to study protein interactions and conformation changes in situ. [30] FRET occurs when two fluorophores with an overlap in their emission and excitation are within close proximity (less than 10 nm). (Fig. 3E) . In order to verify the occurrence of FRET, and therefore the colocalisation of the two fluorophores within single combination particles, fluorescence spectra of both single and dual-component nanoparticles were obtained (Fig. 3 ). An excitation wavelength (λ DiO ex ) of 420 nm was found to give good discrimination between DiO and DiI single-component nanosuspensions (SI Figure 5S) ; we found no effect on the emission peak wavelength when varying the excitation wavelength of any of the fluorescent nanosuspensions, therefore no red-edge excitation shift [31, 32] was observed. The singlecomponent nanosuspension of DiO showed a peak emission (λ DiO em ) at 545 nm ( Fig. 3A) , Particle breakdown or dissolution may also be observed by monitoring the FRET signal within the dual-component nanoparticles. As the particles begin to dissolve the two fluorophores are no longer co-localized within the particles and the distance between the donor and acceptor increases. For example, after dissolution of the DiO 50 /DiI 50 dualcomponent nanosuspension in methanol, FRET was found to be greatly reduced ( Fig. 4C) with the FRET ratio (the wavelengths chosen to represent the two fluorophores are adjusted to account for blue shift) reduced from 0.98 in water to 0.19 as a dissolved solution.
Additionally, DLS analysis of the methanol solutions did not yield sufficient scattering for accurate size measurement, providing further evidence that particle dissolution had occurred.
When a similar methanol dissolution was performed on a mixture (1:1 Figure 5B ). There was no visual evidence of aggregation of the nanosuspensions in the bulk media and separate DLS measurements of the nanosuspension in media confirmed no increase in particle size (SI Figure 6S ). Although the mechanism of cellular uptake requires further investigation, a putative hypothesis is phagocytosis. Observation of Caco-2 cells showed very limited internalization of nanoparticles (SI Figure 8S ) with the majority of particles adhered to the cell surface ( Fig. 5E&F) . While, cellular uptake of nanoparticles into Caco-2 cells has been shown in the literature, [34] [35] [36] it also been reported to be highly dependent on a range of factors including size, [34, 37] shape, [37] hydrophilicity [35] and composition. [35] The low levels of uptake into Caco-2 cells, for the dual-component particles, was surprising however may be driven by a combination factors specific to our particles (eg the elongated shape and surface charge).
The apparent differences in cellular uptake supports the hypothesis that the primary internalization mechanism is phagocytosis as Caco-2 cells are not phagocytic. [21] Full spectral analysis (lambda scan) of the emission of individual pixels within the confocal microscopy images allows quantification of the FRET ratio. This reports the physical state of the DiO 50 /DiI 50 dual-component nanoparticles in the A-THP-1 cells (Fig. 6A&B) . The emission spectra at a number of representative regions of interest (ROI) (up to 11 ROIs) inside the cells showed a clear difference between dual-component nanoparticles and the corresponding 1:1 mixture of DiO and DiI single-component nanoparticles (Fig. 6A&C) . Figure 12S ), showed identical fluorescence spectra over a range of pH values (4.8-8.9). Investigation of the FRET ratios over the three time points showed that the FRET ratios remained constant over time for both dual-component ( Fig. 6F ) and the mixture of single-component nanoparticles (Fig. 6G) ,
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while the single-component particles seemed to display slightly greater accumulation.
Comparison of the FRET ratios from within the cell (after 24 hours) against those of the aqueous dispersion (SI Figure 11S C) showed that the dual-component nanoparticles may have undergone slight particle dissolution as the FRET ratio decreased from 0.97 to 0.89.
Overall, these findings provide strong evidence that the dual-component nanoparticles are analyzed by fluorimetry ( Fig. 7) to quantify the concentration of fluorophore that had transported through the monolayer. The low concentrations of fluorophore detected in the basolateral chamber indicated a low level of transport and required an excitation wavelength of 458 nm to increase overall emission from the samples. This wavelength provides less discrimination between FRET and DiI excitation/emission but this compromise was necessary to increase sensitivity and allow accurate fluorophore quantification.
The emission spectra (Fig. 7A) Figure 8S) would also indicate that the nanoparticles may have traversed the monolayer via a paracellular route, between the cells, rather than by permeation through the cell. Paracellular movement of nanoparticles has been shown previously, [39] in the presence of chitosan either as particles or as dissolved molecules, enhancing drug transition through Caco-2 monolayers. [40] [41] [42] It has been suggested that chitosan, carrying a permanent positive charge, causes reversible opening in the paracellular channels due to electrostatic interactions resulting in disruption of the tight junctions. [42, 43] It is possible that the cationic character of our dual-component nanoparticles led to a similar disruption within the tight junctions. The potential for paracellular movement of the nanoparticles presented here is not completely intuitive, as our particles contain no chitosan. Further study, which may add considerable understanding to the enhanced bioavailability and pharmacokinetics observed for many nanosuspension medicines, is therefore required.
Conclusions
Unlike previous nanosuspension techniques, we have controllably generated a range of The passage of intact nanoparticles across intestinal epithelial cells has implications that require further study as this may clarify mechanisms of modified in vivo behavior of current and potential nanoparticle therapies.
Experimental
Materials. Unless stated otherwise, all of the reagents and solvents were used as received. Particle characterization. The average size and zeta potential of the nanosuspensions were measured at 1 mg/ml at a temperature of 25˚C using a Malvern Zetasizer Nano ZS equipped with a 4mW He-Ne, 633nm laser. The z-average diameters and polydispersity indexes were obtained by DLS. Malvern Zetasizer software version 6.20 was used for data analysis. Zeta potential measurements were also carried out at 1 mg/ml, at 25˚C, a pH of 6.5, using disposable capillary zeta cells. The fluorescence spectra of the nanoparticle dispersion were obtained on a PerkinElmer LS55 using disposable UV-grade PMMA cuvettes with a path length of 1 cm. For fluorescence spectrometry the emulsion-templated solids were dispersed in deionised water to a fluorophore concentration of 0.032 mg/ml. For the dissolution in methanol experiments the solids were first dispersed in water at 1 mg/ml which was then dissolved in methanol to a concentration of 0.016 mg/ml. The excitation and emission slits were unchanged when measuring spectra that were directly compared and no normalization of the data was carried out.
Electron microscopy. Prior to electron microscopy the dual-component sample (DiO 50 /DiI 50 ) was dialyzed for 4 days using a biodialyzer fitted with cellulose acetate membranes with a molecular weight cut-off of 50,000 daltons (Harvard Apparatus) (dialysis was found to have no effect on particle size (SI Figure 4S) ). All electron microscopy images were obtained with the sample deposited on a modified TEM grid, these were prepared as follows: Solutions of graphene oxide [28] were synthesized as previously reported. GO Well HTS Transwell support plates (Corning Ltd) and allowed to propagate, differentiate and polarize over a 21 day period as previously described, [38] where the cell media (DMEM containing 15% FBS) was replaced every other day. The emulsion-templated solids were dispersed in deionised water to a fluorophore concentration of 1.0 mg/ml. These nanosuspensions were then diluted to 50 μM in Hanks buffer containing 0.5mM L-glutamine.
These nanosuspensions were added to the apical compartment (intestinal lumen mimic) and transcellular permeability was assessed by fluorimetry (PerkinElmer LS55) after pooling the recipient buffer contained in 5 basolateral compartments after 18 hours incubation. For the excitation spectra measurements the nanosuspensions were at 0.032 mg/ml and the emission wavelength was set to 550 nm for the DiO nanosuspension and 600 nm for the DiI or dual-component nanosuspensions. 
